Barings’s Merck MRK Stock Holding History

Barings’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2,011	Closed	-$212K	–	187
2025 Q4	$212K	Buy	+2,011	New	+$189K	﹤0.01%	158
2023 Q3	–	Sell	-2,400	Closed	-$277K	–	167
2023 Q2	$277K	Sell	2,400 -770	-24%	-$87.4K	0.01%	146
2023 Q1	$337K	Sell	3,170 -242	-7%	-$26.1K	0.01%	133
2022 Q4	$379K	Sell	3,412 -49	-1%	-$5.01K	0.01%	151
2022 Q3	$298K	Sell	3,461 -14,428	-81%	-$1.29M	0.01%	158
2022 Q2	$1.63M	Buy	17,889 +1,009	+6%	+$89.5K	0.06%	132
2022 Q1	$1.39M	Sell	16,880 -3,620	-18%	-$285K	0.04%	158
2021 Q4	$1.57M	Sell	20,500 -1,106	-5%	-$88.1K	0.04%	167
2021 Q3	$1.62M	Buy	21,606 +5,109	+31%	+$389K	0.04%	161
2021 Q2	$1.28M	Sell	16,497 -2,347	-12%	-$175K	0.03%	192
2021 Q1	$1.39M	Buy	18,844 +1,677	+10%	+$124K	0.03%	196
2020 Q4	$1.34M	Sell	17,167 -99,752	-85%	-$7.63M	0.03%	201
2020 Q3	$9.26M	Sell	116,919 -14,547	-11%	-$1.14M	0.21%	79
2020 Q2	$9.65M	Hold	131,466	–	–	0.32%	62
2020 Q1	$9.65M	Buy	131,466 +10,067	+8%	+$791K	0.32%	62
2019 Q4	$10.5M	Sell	121,399 -32,009	-21%	-$2.63M	0.28%	61
2019 Q3	$12.3M	Buy	153,408 +6	+0%	+$481	0.28%	79
2019 Q2	$12.3M	Buy	153,402 +55,772	+57%	+$4.27M	0.27%	80
2019 Q1	$7.75M	Buy	97,630 +11,738	+14%	+$878K	0.18%	100
2018 Q4	$6.26M	Sell	85,892 -2,096	-2%	-$148K	0.11%	121
2018 Q3	$5.96M	Buy	87,988 +12,157	+16%	+$775K	0.08%	158
2018 Q2	$4.39M	Sell	75,831 -36,242	-32%	-$2.04M	0.06%	199
2018 Q1	$5.83M	Hold	112,073	–	–	0.08%	162
2017 Q4	$6.02M	Hold	112,073	–	–	0.08%	181
2017 Q3	$6.85M	Hold	112,073	–	–	0.12%	108
2017 Q2	$6.85M	Sell	112,073 -76,651	-41%	-$4.67M	0.2%	100
2017 Q1	$11.4M	Buy	188,724 +75,393	+67%	+$4.57M	0.13%	145
2016 Q4	$6.37M	Sell	113,331 -28,505	-20%	-$1.67M	0.16%	68
2016 Q3	$8.45M	Sell	141,836 -29,659	-17%	-$1.73M	0.22%	52
2016 Q2	$9.43M	Sell	171,495 -5,973	-3%	-$318K	0.24%	50
2016 Q1	$8.96M	Sell	177,468 -82,478	-32%	-$4.04M	0.24%	52
2015 Q4	$13.1M	Buy	259,946 +14,986	+6%	+$756K	0.33%	37
2015 Q3	$11.5M	Sell	244,960 -82,103	-25%	-$4.36M	0.28%	43
2015 Q2	$17.8M	Buy	327,063 +164,536	+101%	+$9.23M	0.54%	32
2015 Q1	$8.91M	Sell	162,527 -97,254	-37%	-$5.51M	0.2%	64
2014 Q4	$14.1M	Sell	259,781 -12,262	-5%	-$683K	0.31%	38
2014 Q3	$15.4M	Buy	272,043 +60,050	+28%	+$3.37M	0.33%	42
2014 Q2	$11.7M	Buy	211,993 +1,887	+0.9%	+$103K	0.35%	52
2014 Q1	$11.4M	Buy	210,106 +27,248	+15%	+$1.41M	0.36%	49
2013 Q4	$8.73M	Sell	182,858 -43,911	-19%	-$2.01M	0.36%	54
2013 Q3	$10.3M	Sell	226,769 -1,572	-0.7%	-$71.8K	0.44%	42
2013 Q2	$10.1M	Buy	+228,341	New	+$10.2M	0.45%	45

Other funds holding MRK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Barings's MRK Position: Q1 2026 in Review

Barings sold out of Merck (MRK) in Q1 2026, closing a stake of 2,011 shares — an estimated $212K sold.

Barings first reported a position in MRK in Q2 2013 and held it in 42 quarters. The position peaked at $17.8M in Q2 2015. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

Barings reported no remaining Merck position as of Q1 2026 after selling out during the quarter.
Barings sold 2,011 Merck shares in Q1 2026, an estimated $212K.
Barings first reported a position in Merck in Q2 2013 and held it in 42 quarters.
Barings's Merck position peaked at $17.8M in Q2 2015.
3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Barings's 13F filing for Q1 2026, filed 6 May 2026.